• Explore /
  • Poster
  • / Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) stage IV colorectal cancer (CRC).

Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) stage IV colorectal cancer (CRC).

Abstract Poster

Authors

Thierry Andre

Thierry Andre

Hôpital Saint-Antoine, Paris, France

Thierry Andre , Caterina Sposetti , Mahmut Gumus , Joong Bae Ahn , Lucjan Wyrwicz , Mariusz Kwiatkowski , Jong Gwang Kim , Suayib Yalcin , Mehmet A.N. Sendur , Amos Odeleye-Ajakaye , Pierre Leconte , David R. Fogelman , Tae Won Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT04895722

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS3639)

DOI

10.1200/JCO.2022.40.16_suppl.TPS3639

Abstract #

TPS3639

Poster Bd #

427b

Abstract Disclosures

Similar Posters

First Author: Girish S. Kulkarni

First Author: Robert J. Motzer

First Author: Dung T. Le

First Author: David Lavie